http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011097263-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91943488b68ac64c91e5a094819621d6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6913 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1234 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 |
| filingDate | 2009-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db313c938bfbd1cafe2f12a68f01a2df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f41bb022f72d541a15f93ea34f172cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97e1eeb23ec12fd07e57a8edd68fe581 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d545ce611de0e90a96d034a47d4a419b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff26e87c492fe12a538774f25412b39d |
| publicationDate | 2011-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2011097263-A1 |
| titleOfInvention | Kit formulation for the preparation of immunoliposome drug in combined bimodality radiochemotherapy |
| abstract | A kit formulation for the preparation of immunoliposome drug in combined chemotherapy and radionuclide therapy is disclosed, which consists: (1) a vial A containing proteins; (2) a vial B containing Traut's reagent; (3) a vial C containing DSPC, Cholesterol, mPEG-DSPE, Mal-DSPE-PEG and chemotherapy drug; (4) a vial D containing BMEDA, gluconate acetate, SnCl 2 ; (5) a vial E which containing radionuclide solution. The procedure using the kit comprises: (i) withdraw the radionuclide solution from the vial E; (ii) inject the solution into the vial D for enabling reaction; (iii) withdraw the contents of the vial B and inject into the vial A; (iv) withdraw the contents of the protein and Traut's reagent mixtures from the vial A and inject into the vial C for enabling reaction; (v) withdraw the contents of the immunoliposome from the vial C; (vi) inject the immunoliposome into the vial D of step (ii) for enabling reaction. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2803653-A1 |
| priorityDate | 2009-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 80.